SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-011597
Filing Date
2019-09-10
Accepted
2019-09-10 17:14:13
Documents
1
Period of Report
2019-09-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxcaldolorupdatesept2019.htm 8-K 33722
  Complete submission text file 0001628280-19-011597.txt   34726
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 191086178
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1